Special Issue "Pharmaceuticals and Nutraceuticals by Molecular Farming"
Deadline for manuscript submissions: closed (30 May 2014).
Interests: plant-derived biomedicines; plant-made pharmaceuticals; molecular farming; recombinant proteins; plant metabolic engineering; hypoglycaemic; hypolipidemic; antioxidants; antiviral; bacterial ghost vaccine; inactivated vaccine; subunit vaccine
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Plant-Derived Pharmaceuticals by Molecular Farming
Special Issue in International Journal of Molecular Sciences: Plant-Derived Pharmaceuticals by Molecular Farming 2012
Special Issue in International Journal of Molecular Sciences: Plant-Derived Pharmaceuticals by Molecular Farming 2016
Special Issue in International Journal of Molecular Sciences: Advances in Cheap Vaccines for Public Goods
Special Issue in International Journal of Molecular Sciences: New Advances in Human Vaccine
Special Issue in International Journal of Molecular Sciences: New Challenges in Human & Animal Vaccines
Molecular farming (MF), in terms of production scale and economy, product safety, ease of storage, and distribution, is superior to any other current commercial alternative. Despite MF’s promising benefits, the commercialization of MF-derived products is lagging behind due to uncertainty and safety issues. A particularly troubling issue concerns the adaptation of good manufacturing practice regulations for transgenic organisms. Although MF is not yet routinely commercialized, interest and investment in MF are extending rapidly. Ultimately, MF will progress and become a core commercial development in biotechnology.
This Special Issue aims to provide high quality research concerning novel gene expression in target organisms, MF’s industrial and preclinical/clinical applications, and MF’s environmental impacts. Possible topics cover research at both the basic and applied sciences levels, and concern yeast, fungi, algae, insects, plants, fish or mammals. Possible products include biopharmaceuticals, nutraceuticals, vaccines, metabolites, and proteins for industrial purposes. I wish to thank all authors for their contributions to this Special Issue.
Dr. Chang Won Choi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular farming
- transgenic organisms
- industrial, preclinical/clinical applications
- environmental impacts
- yeast, fungi, algae, insects, plants, fish, mammals, biopharmaceuticals, nutraceuticals, vaccines, metabolites, proteins for industrial purposes